fda d.i.s.c.o. burst edition: fda approval of imjudo (tremelimumab) in combination with imfinzi (...
Published 6 months ago • 71 plays • Length 3:01Download video MP4
Download video MP3
Similar videos
-
5:31
fda d.i.s.c.o. burst edition: fda approvals of imjudo (tremelimumab) in combination with durvalum...
-
6:01
fda d.i.s.c.o.: osimertinib for non-small cell lung cancer
-
0:42
astrazeneca’s immunotherapy imjudo (tremelimumab) wins fda approval for liver cancer
-
7:44
durvalumab (imfinzi) fda approved for stage iii nsclc: standard of care? (bmic-024)
-
1:36
fda approval of durvalumab for stage iii unresectable nsclc
-
29:37
what is pf/ild: disease pathways and treatment
-
2:49
durvalumab - imfinzi - all you need to know in 2 minutes.
-
1:01:24
introduction to bronchiectasis with tim aksamit, md
-
2:43
fda approves durvalumab / imfinzi for resectable nsclc non-small cell lung cancer
-
1:15
dr. spigel on fda approval of pembrolizumab/chemo combo in nsclc
-
7:35
fda approval for abemaciclib
-
10:42
fda approvals of a biosimilar and dtc genetic test, breakthrough designation in mzl, and more
-
7:44
fda approvals for daratumumab and osimertinib, regulatory advances in rcc and cll, and more
-
0:58
an expert’s thoughts on the fda approval of durvalumab in locally advanced lung cancers
-
0:46
fda approves capmatinib for advanced lung cancer
-
6:01
fda d.i.s.c.o.: osimertinib for non-small cell lung cancer
-
0:53
dr. siefker-radtke on fda approval of durvalumab in bladder cancer
-
3:01
new fda approved treatment for lung cancer (fcl july 2nd 2020)
-
4:17
fda approves atezolizumab as adjuvant treatment for non-small cell lung cancer
-
1:35
dr. fakih on durvalumab and tremelimumab in crc
-
14:10
medical fair asia 2020 digital edition - technical presentation